Antimicrobial Technology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510242383

Publication Date:

October 17, 2024

Pages:

108

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Antimicrobial Technology was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Antimicrobial Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Antimicrobial Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Antimicrobial Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Antimicrobial Technology include Heraeus, BioCote Ltd, Microban, AIONX, Life Material, Poly, Bio Shield Technologies, TECcare and Avient, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antimicrobial Technology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Antimicrobial Technology by region & country, by Type, and by Application.
The Antimicrobial Technology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antimicrobial Technology.
Market Segmentation
By Company
Heraeus
BioCote Ltd
Microban
AIONX
Life Material
Poly
Bio Shield Technologies
TECcare
Avient
Valli&Valli
Westex
Segment by Type:
Based on Metal Ion Release
Based on the Release of Organic Substances
Other
Segment by Application
Medical
Textile
Chemical Industry
Agriculture
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antimicrobial Technology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Antimicrobial Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Antimicrobial Technology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Antimicrobial Technology Product Introduction
1.2 Global Antimicrobial Technology Market Size Forecast
1.3 Antimicrobial Technology Market Trends & Drivers
1.3.1 Antimicrobial Technology Industry Trends
1.3.2 Antimicrobial Technology Market Drivers & Opportunity
1.3.3 Antimicrobial Technology Market Challenges
1.3.4 Antimicrobial Technology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Antimicrobial Technology Players Revenue Ranking (2023)
2.2 Global Antimicrobial Technology Revenue by Company (2019-2024)
2.3 Key Companies Antimicrobial Technology Manufacturing Base Distribution and Headquarters
2.4 Key Companies Antimicrobial Technology Product Offered
2.5 Key Companies Time to Begin Mass Production of Antimicrobial Technology
2.6 Antimicrobial Technology Market Competitive Analysis
2.6.1 Antimicrobial Technology Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Antimicrobial Technology Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Technology as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Based on Metal Ion Release
3.1.2 Based on the Release of Organic Substances
3.1.3 Other
3.2 Global Antimicrobial Technology Sales Value by Type
3.2.1 Global Antimicrobial Technology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Antimicrobial Technology Sales Value, by Type (2019-2030)
3.2.3 Global Antimicrobial Technology Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medical
4.1.2 Textile
4.1.3 Chemical Industry
4.1.4 Agriculture
4.1.5 Other
4.2 Global Antimicrobial Technology Sales Value by Application
4.2.1 Global Antimicrobial Technology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Antimicrobial Technology Sales Value, by Application (2019-2030)
4.2.3 Global Antimicrobial Technology Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Antimicrobial Technology Sales Value by Region
5.1.1 Global Antimicrobial Technology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Antimicrobial Technology Sales Value by Region (2019-2024)
5.1.3 Global Antimicrobial Technology Sales Value by Region (2025-2030)
5.1.4 Global Antimicrobial Technology Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Antimicrobial Technology Sales Value, 2019-2030
5.2.2 North America Antimicrobial Technology Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Antimicrobial Technology Sales Value, 2019-2030
5.3.2 Europe Antimicrobial Technology Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Antimicrobial Technology Sales Value, 2019-2030
5.4.2 Asia Pacific Antimicrobial Technology Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Antimicrobial Technology Sales Value, 2019-2030
5.5.2 South America Antimicrobial Technology Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Antimicrobial Technology Sales Value, 2019-2030
5.6.2 Middle East & Africa Antimicrobial Technology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Antimicrobial Technology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Antimicrobial Technology Sales Value
6.3 United States
6.3.1 United States Antimicrobial Technology Sales Value, 2019-2030
6.3.2 United States Antimicrobial Technology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Antimicrobial Technology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Antimicrobial Technology Sales Value, 2019-2030
6.4.2 Europe Antimicrobial Technology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Antimicrobial Technology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Antimicrobial Technology Sales Value, 2019-2030
6.5.2 China Antimicrobial Technology Sales Value by Type (%), 2023 VS 2030
6.5.3 China Antimicrobial Technology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Antimicrobial Technology Sales Value, 2019-2030
6.6.2 Japan Antimicrobial Technology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Antimicrobial Technology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Antimicrobial Technology Sales Value, 2019-2030
6.7.2 South Korea Antimicrobial Technology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Antimicrobial Technology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Antimicrobial Technology Sales Value, 2019-2030
6.8.2 Southeast Asia Antimicrobial Technology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Antimicrobial Technology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Antimicrobial Technology Sales Value, 2019-2030
6.9.2 India Antimicrobial Technology Sales Value by Type (%), 2023 VS 2030
6.9.3 India Antimicrobial Technology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Heraeus
7.1.1 Heraeus Profile
7.1.2 Heraeus Main Business
7.1.3 Heraeus Antimicrobial Technology Products, Services and Solutions
7.1.4 Heraeus Antimicrobial Technology Revenue (US$ Million) & (2019-2024)
7.1.5 Heraeus Recent Developments
7.2 BioCote Ltd
7.2.1 BioCote Ltd Profile
7.2.2 BioCote Ltd Main Business
7.2.3 BioCote Ltd Antimicrobial Technology Products, Services and Solutions
7.2.4 BioCote Ltd Antimicrobial Technology Revenue (US$ Million) & (2019-2024)
7.2.5 BioCote Ltd Recent Developments
7.3 Microban
7.3.1 Microban Profile
7.3.2 Microban Main Business
7.3.3 Microban Antimicrobial Technology Products, Services and Solutions
7.3.4 Microban Antimicrobial Technology Revenue (US$ Million) & (2019-2024)
7.3.5 AIONX Recent Developments
7.4 AIONX
7.4.1 AIONX Profile
7.4.2 AIONX Main Business
7.4.3 AIONX Antimicrobial Technology Products, Services and Solutions
7.4.4 AIONX Antimicrobial Technology Revenue (US$ Million) & (2019-2024)
7.4.5 AIONX Recent Developments
7.5 Life Material
7.5.1 Life Material Profile
7.5.2 Life Material Main Business
7.5.3 Life Material Antimicrobial Technology Products, Services and Solutions
7.5.4 Life Material Antimicrobial Technology Revenue (US$ Million) & (2019-2024)
7.5.5 Life Material Recent Developments
7.6 Poly
7.6.1 Poly Profile
7.6.2 Poly Main Business
7.6.3 Poly Antimicrobial Technology Products, Services and Solutions
7.6.4 Poly Antimicrobial Technology Revenue (US$ Million) & (2019-2024)
7.6.5 Poly Recent Developments
7.7 Bio Shield Technologies
7.7.1 Bio Shield Technologies Profile
7.7.2 Bio Shield Technologies Main Business
7.7.3 Bio Shield Technologies Antimicrobial Technology Products, Services and Solutions
7.7.4 Bio Shield Technologies Antimicrobial Technology Revenue (US$ Million) & (2019-2024)
7.7.5 Bio Shield Technologies Recent Developments
7.8 TECcare
7.8.1 TECcare Profile
7.8.2 TECcare Main Business
7.8.3 TECcare Antimicrobial Technology Products, Services and Solutions
7.8.4 TECcare Antimicrobial Technology Revenue (US$ Million) & (2019-2024)
7.8.5 TECcare Recent Developments
7.9 Avient
7.9.1 Avient Profile
7.9.2 Avient Main Business
7.9.3 Avient Antimicrobial Technology Products, Services and Solutions
7.9.4 Avient Antimicrobial Technology Revenue (US$ Million) & (2019-2024)
7.9.5 Avient Recent Developments
7.10 Valli&Valli
7.10.1 Valli&Valli Profile
7.10.2 Valli&Valli Main Business
7.10.3 Valli&Valli Antimicrobial Technology Products, Services and Solutions
7.10.4 Valli&Valli Antimicrobial Technology Revenue (US$ Million) & (2019-2024)
7.10.5 Valli&Valli Recent Developments
7.11 Westex
7.11.1 Westex Profile
7.11.2 Westex Main Business
7.11.3 Westex Antimicrobial Technology Products, Services and Solutions
7.11.4 Westex Antimicrobial Technology Revenue (US$ Million) & (2019-2024)
7.11.5 Westex Recent Developments
8 Industry Chain Analysis
8.1 Antimicrobial Technology Industrial Chain
8.2 Antimicrobial Technology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Antimicrobial Technology Sales Model
8.5.2 Sales Channel
8.5.3 Antimicrobial Technology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Heraeus
BioCote Ltd
Microban
AIONX
Life Material
Poly
Bio Shield Technologies
TECcare
Avient
Valli&Valli
Westex

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂